David Einhorn
Greenlight Capital
David Einhorn Nuvation Bio Inc stake
total: 357
Greenlight Capital NUVB trades
- Total transactions:
- 2
- New positions:
- 1
- Reduced:
- 1
- Held since:
- 2021 Q1
- Held for:
- 22 quarters
- Latest activity:
- 2021 Q2
According to 2026 Q2 report, David Einhorn holds 34,995 Nuvation Bio Inc (NUVB) shares with a market value of roughly $198.77K accounting for 0.01% of the overall portfolio. To date, the estimated cost basis is nearly $10.45 for "buy" trades and estimated average "sell" price is $9.32. Greenlight Capital first purchased NUVB in 2021 Q1, initially acquiring 150,000 shares. Since the initial investment in Nuvation Bio Inc (NUVB), Greenlight Capital has made 1 more transaction.
When did David Einhorn buy Nuvation Bio Inc (NUVB)?
David Einhorn first invested in Nuvation Bio Inc (NUVB) in 2021 Q1 at the reported quarter-end price of $10.45 per share.
What's the cost basis of Greenlight Capital's NUVB stake?
The estimated cost basis for Nuvation Bio Inc (NUVB) stake is around $10.45 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.45
- Weighted AVG sell price:
- $9.32
David Einhorn's historical trades in Nuvation Bio Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q2
|
0.02%
|
34,995
|
$9.32
|
$326,000
|
-76.67% (-115,005)
|
-0.07%
|
|
2021 Q1
|
0.11%
|
150,000
|
$10.45
|
$1,568,000
|
new
|
+0.11%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.